factually
Index/Organizations/BacoMind

BacoMind

Fact-Checks

3 results
Jan 30, 2026
Most Viewed

What evidence exists for the efficacy and safety of common nootropic ingredients claimed by MindBoost (Bacopa, Ginkgo, vitamin D, etc.)?

Clinical evidence for common sold by products like is mixed but suggests modest, domain-specific cognitive benefits for monnieri and in some populations, with generally mild adverse-event profiles rep...

Jan 9, 2026
Most Viewed

What are the standardized doses and durations used in randomized trials of Bacopa monnieri for memory in older adults?

Randomized trials of Bacopa monnieri in older adults most commonly test daily extract doses in the 300–600 mg range, with treatment periods clustered at about 12 weeks (three months); some studies hav...

Feb 3, 2026

What standardized bacopa monnieri extracts were used in the positive clinical trials and how do commercial products compare?

Clinical studies that report positive cognitive or anxiolytic effects most often used characterized, extracts — notably 08, ® and older proprietary preparations such as ®/® — typically dosed at roughl...